Montet J C, Lindheimer M, Reynier M O, Crotte C, Bontemps R, Gerolami A
Biochimie. 1982 Apr;64(4):255-61. doi: 10.1016/s0300-9084(82)80492-6.
The solubilizing powers of taurocholate, taurochenodeoxycholate and tauroursodeoxycholate for monoolein and cholesterol, and the size of the bile salt-monoolein-cholesterol micelles have been determined. For the three bile salt species, the micellar size depends on the saturation with monoolein. As a result, for a given bile salt to monoolein ratio, the taurochenodeoxycholate micelles are smaller than those of taurocholate and both are smaller than those of tauroursodeoxycholate. Intestinal cholesterol uptake has been studied in vitro as a function of the micellar size and the saturation degree with cholesterol. For a given bile salt to monoolein ration and 1) for low cholesterol concentrations, taurocholate leads to the greatest rates of uptake ; 2) for high cholesterol content, taurochenodeoxycholate induces the largest uptake. The specific micellar characteristics of the tauroursodeoxycholate micelles clearly demonstrate why this bile salt is of so little help in the intestinal uptake of cholesterol.
已测定牛磺胆酸盐、牛磺鹅去氧胆酸盐和牛磺熊去氧胆酸盐对单油酸甘油酯和胆固醇的增溶能力,以及胆盐 - 单油酸甘油酯 - 胆固醇胶束的大小。对于这三种胆盐,胶束大小取决于单油酸甘油酯的饱和度。因此,在给定的胆盐与单油酸甘油酯比例下,牛磺鹅去氧胆酸盐胶束小于牛磺胆酸盐胶束,且二者均小于牛磺熊去氧胆酸盐胶束。已在体外研究了肠道胆固醇摄取与胶束大小及胆固醇饱和度的关系。对于给定的胆盐与单油酸甘油酯比例,且1)在低胆固醇浓度时,牛磺胆酸盐导致最大摄取率;2)在高胆固醇含量时,牛磺鹅去氧胆酸盐诱导最大摄取量。牛磺熊去氧胆酸盐胶束的特定胶束特性清楚地表明了为何这种胆盐在肠道胆固醇摄取方面几乎没有帮助。